Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Is there a genotype-phenotype correlation in primary hyperoxaluria type 1?

B B Beck1, B Hoppe

  • 1Division of Pediatric Nephrology, University Children's Hospital, Cologne, Germany. Bernd.Hoppe@uk-koeln.de

Kidney International
|September 8, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[SAPHO-Synovitis, acne, pustulosis, hyperosteosis, osteitis].

Radiologie (Heidelberg, Germany)·2025
Same author

Liquid and Dry Swabs for Culture- and PCR-Based Detection of Colonization with Methicillin-Resistant Staphylococcus aureus during Admission Screening.

European journal of microbiology & immunology·2020
Same author

Rapid liquid chromatography tandem mass-spectrometry screening method for urinary metabolites of primary hyperoxaluria.

Annals of clinical biochemistry·2018
Same author

[Biomarkers and imaging for diagnosis and stratification of rheumatoid arthritis and spondylarthritis in the BMBF consortium ArthroMark].

Zeitschrift fur Rheumatologie·2018
Same author

Monitoring of complement activation biomarkers and eculizumab in complement-mediated renal disorders.

Clinical and experimental immunology·2016
Same author

Extrarenal Manifestations in Shigatoxin-associated Haemolytic Uremic Syndrome.

Klinische Padiatrie·2016

Primary hyperoxaluria type 1 (PH1) disease severity varies even with the same AGXT mutation. Environmental factors and modifier genes likely influence PH1 progression, not just genetics.

Area of Science:

  • Nephrology
  • Genetics
  • Metabolic Disorders

Background:

  • Primary hyperoxaluria type 1 (PH1) is a rare genetic kidney disease.
  • The AGXT gene encodes the alanine-glyoxylate aminotransferase enzyme, crucial for oxalate metabolism.
  • Mutations in AGXT cause PH1, leading to kidney stone formation and renal failure.

Discussion:

  • The correlation between specific AGXT mutations and PH1 clinical presentation is debated.
  • Disease heterogeneity suggests other factors beyond genotype influence phenotype.
  • Lorenzo and colleagues' study examines a population with a single AGXT mutation to explore these other determinants.

Key Insights:

  • Genotype-phenotype correlations in PH1 are complex and not fully understood.
  • Environmental influences and genetic modifiers are critical factors in PH1 disease progression.

Related Experiment Videos

  • Understanding these additional factors is essential for accurate PH1 diagnosis and management.

    • Outlook:

    • Further research is needed to elucidate the impact of environmental factors and modifier genes on PH1.
    • This knowledge could lead to personalized treatment strategies for PH1 patients.
    • Developing targeted therapies based on individual genetic and environmental profiles is a future goal.